What does this research mean for the field?

Concomitant use of simvastatin and amiodarone can precipitate severe myopathy and rhabdomyolysis due to the inhibition of CYP3A4-dependent statin metabolism. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To report a case of severe myopathy and rhabdomyolysis associated with the concomitant administration of simvastatin and amiodarone.

April 12, 2004Annals of Pharmacotherapy

Rhabdomyolysis in Association with Simvastatin and Amiodarone

View Full Paper

Ask AI

Bookmark

Why the study?

Does concomitant use of simvastatin and amiodarone cause severe myopathy?

Key Points

To report a case of severe myopathy and rhabdomyolysis associated with the concomitant administration of simvastatin and amiodarone.
Clinical and laboratory evaluation of a 63-year-old male presenting with weakness and muscle pain after starting simvastatin (40 mg/day) and amiodarone (1 g/day loading, then 200 mg/day).
Monitoring of serum creatine kinase concentrations and patient recovery following the discontinuation of both interacting drugs.
The patient developed generalized muscle weakness and severe rhabdomyolysis, with serum creatine kinase concentrations peaking at 40,392 U/L.
Discontinuation of both simvastatin and amiodarone led to normalization of creatine kinase levels over 8 days and full clinical recovery.
Causality assessment linked the myopathy to CYP3A4 inhibition by amiodarone, which impaired simvastatin elimination.

Structured PICO

Does concomitant use of simvastatin and amiodarone cause severe myopathy?

Population

1 63-year-old white man with insulin-dependent diabetes, recent coronary artery bypass surgery, postoperative hemiplegia, and recurrent atrial fibrillation.

Intervention

Concomitant use of simvastatin 40 mg/day and amiodarone (1 g/day for 10 days, then 200 mg/day)

Outcome

Development of severe myopathy/rhabdomyolysis (diffuse muscle pain, generalized muscular weakness, and increased creatine kinase)safety

Concomitant use of simvastatin and amiodarone can lead to severe myopathy due to CYP3A4 inhibition by amiodarone, highlighting the importance of avoiding this combination or selecting a statin not metabolized by CYP3A4.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Suspected simvastatin-amiodarone interaction may cause severe myopathy; case report leaves open need for prospective interaction studies.

Cite This Study

Roten et al. (2004) studied this question.

synapsesocial.com/papers/6a1a4dcafebba9eb7c350659 https://doi.org/10.1345/aph.1d498

Topics

Statin therapy

View Full Paper

Ask AI

Bookmark

Rhabdomyolysis in Association with Simvastatin and Amiodarone

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Topics

Rhabdomyolysis in Association with Simvastatin and Amiodarone

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Keep reading

Topics

Keep reading